Tumor suppressor p53 inactivation is frequently associated with chemotherapy resistance in AML, and suppress of p53 signaling contributes to the resistance towards apoptosis in leukemia cells [22, 23]. This evidence concerns the gene TP53 and acute myeloid leukemia.